[go: up one dir, main page]

DE68920797D1 - Heart medication. - Google Patents

Heart medication.

Info

Publication number
DE68920797D1
DE68920797D1 DE68920797T DE68920797T DE68920797D1 DE 68920797 D1 DE68920797 D1 DE 68920797D1 DE 68920797 T DE68920797 T DE 68920797T DE 68920797 T DE68920797 T DE 68920797T DE 68920797 D1 DE68920797 D1 DE 68920797D1
Authority
DE
Germany
Prior art keywords
heart medication
medication
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68920797T
Other languages
German (de)
Other versions
DE68920797T2 (en
Inventor
Takafumi Fujioka
Shuji Teramoto
Michiaki Tominaga
Yoichi Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE68920797D1 publication Critical patent/DE68920797D1/en
Publication of DE68920797T2 publication Critical patent/DE68920797T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DE68920797T 1988-08-10 1989-08-09 Heart medication. Expired - Fee Related DE68920797T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20092988 1988-08-10
JP3468889 1989-02-14
JP16017089 1989-06-21

Publications (2)

Publication Number Publication Date
DE68920797D1 true DE68920797D1 (en) 1995-03-09
DE68920797T2 DE68920797T2 (en) 1995-06-29

Family

ID=27288505

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68920797T Expired - Fee Related DE68920797T2 (en) 1988-08-10 1989-08-09 Heart medication.

Country Status (7)

Country Link
US (2) US5053514A (en)
EP (1) EP0355583B1 (en)
JP (1) JP2648970B2 (en)
KR (1) KR0139626B1 (en)
DE (1) DE68920797T2 (en)
DK (1) DK391189A (en)
ES (1) ES2070151T3 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
TW201305B (en) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
US5506239A (en) * 1991-08-23 1996-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelets aggregation inhibitory agent
DK0660715T3 (en) * 1992-09-18 1998-01-19 Otsuka Pharma Co Ltd Carbostyril derivatives as antiarrhythmic agents
JPH06183976A (en) * 1992-09-18 1994-07-05 Otsuka Pharmaceut Co Ltd Antiarrhythmic agent
TW254855B (en) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
AU694295B2 (en) * 1995-01-09 1998-07-16 Otsuka Pharmaceutical Co., Ltd. Use of carbostyril compounds for inhibition of TNF-alpha
CN1254465C (en) 1996-04-09 2006-05-03 Nps医药公司 Calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
HUP0003647A3 (en) * 1997-09-24 2002-12-28 Orion Corp Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates
HU227441B1 (en) † 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (en) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME
AU2003297562A1 (en) * 2002-11-27 2004-06-23 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND Beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
WO2004058726A2 (en) * 2002-12-23 2004-07-15 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
TWI481601B (en) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd Nitrogen-containing compound and pharmaceutical composition
KR102015054B1 (en) * 2015-08-10 2019-08-27 동우 화인켐 주식회사 Negative-type photosensitive resin comopsition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
JPS517672B2 (en) * 1972-04-13 1976-03-10
JPS4951271A (en) * 1972-09-28 1974-05-18
JPS5241270B2 (en) * 1973-01-25 1977-10-17
JPS5082218A (en) * 1973-11-10 1975-07-03
JPS539227B2 (en) * 1973-12-26 1978-04-04
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
DE2805404A1 (en) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-ARYLOXY-3-NITRATOALKYLAMINO-2-PROPANOLS AND METHOD FOR THE PRODUCTION THEREOF
JPS54151985A (en) * 1978-05-17 1979-11-29 Otsuka Pharmaceut Co Ltd Preparation of aminocarbostyril derivative
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DD150456A5 (en) * 1979-03-01 1981-09-02 Ciba Geigy Ag PROCESS FOR THE PREPARATION OF DERIVATIVES OF 3-AMINO-1,2-PROPANDIOL
JPS55129268A (en) * 1979-03-28 1980-10-06 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5695115A (en) * 1979-12-28 1981-08-01 Otsuka Pharmaceut Co Ltd Remedy for glaucoma
JPS568319A (en) * 1980-03-26 1981-01-28 Otsuka Pharmaceut Co Ltd Antihistamine
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
DE3330005A1 (en) * 1983-08-19 1985-02-28 Wolfgang Dr. Graz Lindner TONIC ACID MONOESTERS OF OPTICALLY ACTIVE ALKANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
GB2163150B (en) * 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
EP0255134B1 (en) * 1986-07-31 1993-03-03 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same

Also Published As

Publication number Publication date
EP0355583A2 (en) 1990-02-28
DK391189D0 (en) 1989-08-09
ES2070151T3 (en) 1995-06-01
KR0139626B1 (en) 1998-06-01
DE68920797T2 (en) 1995-06-29
JPH0386864A (en) 1991-04-11
KR900003127A (en) 1990-03-23
US5053514A (en) 1991-10-01
DK391189A (en) 1990-02-11
EP0355583B1 (en) 1995-01-25
US5385914A (en) 1995-01-31
JP2648970B2 (en) 1997-09-03
EP0355583A3 (en) 1991-11-06

Similar Documents

Publication Publication Date Title
DE68917895D1 (en) CATHETER.
ATE120194T1 (en) THERAPEUTIC NULEOSIDES.
FI903656A0 (en) THERAPEUTIC KINUCLIDIN INFOERING.
DE68912814D1 (en) Syringes.
DE3850411D1 (en) CATHETER.
DE3783437D1 (en) MEDICINE.
DE58900730D1 (en) SYRINGE TABLET.
DE68905249D1 (en) BLOOD CONTAINER.
IT8920794A0 (en) HARVESTER.
DE3786814D1 (en) ARTERIEECTOMY CATHETER.
DE3750239D1 (en) Catheter.
DE3786441D1 (en) CATHETER.
DE3678932D1 (en) CATHETER.
ES2017960B3 (en) CATHETER.
ATE98480T1 (en) DRUG FORMULATIONS.
DE3776264D1 (en) VENARY CATHETER.
DE3873024D1 (en) ATHEREECTOMY CATHETER.
FI885026L (en) HAORVAORD MEDICINE.
DE68920797D1 (en) Heart medication.
FI882995A0 (en) HARVESTER.
DE68912596D1 (en) Wound medication.
FI893835L (en) MEDICINE
FI884048A0 (en) FOERFARANDE FOER BESTAEMNING AV HALTEN AV EN GASKOMPONENT I EN PATIENTS ANDNINGSLUFT.
FI893897A0 (en) THERAPEUTIC NUCLEOSIDER.
DE3852496D1 (en) CATHETER.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee